Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sneha Vivekanandhan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Seminars in Cancer Biology|February 8, 2018
Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-β) signaling: An insight into Neuropilin-1 (NRP1) mediated tumorigenesisSneha Vivekanandhan, Debabrata Mukhopadhyay
Cancers|October 27, 2022
Resistance to TrastuzumabSneha Vivekanandhan, Keith L Knutson
Molecular Cancer|February 2, 2023
Immunotherapies in rare cancersSneha Vivekanandhan, Deborah Bahr, Ashish Kothari, et al.
Scientific Reports|October 19, 2024
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanomaEmmanuel M Gabriel, Brian Necela, Deborah Bahr, et al.
Scientific Reports|October 12, 2017
Genetic status of KRAS modulates the role of Neuropilin-1 in tumorigenesisSneha Vivekanandhan, Lijuan Yang, Ying Cao, et al.
Research Square|April 22, 2024
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanomaEmmanuel M Gabriel, Brian Necela, Deborah Bahr, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 13, 2022
Fluconazole Is Neuroprotective via Interactions with the IGF-1 ReceptorValerie Toodle, Myoung-Hwa Lee, Muzna Bachani, et al.
Cancers|August 27, 2021
Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Status of <i>KRAS</i>Sneha Vivekanandhan, Vijay S Madamsetty, Ramcharan Singh Angom, et al.
Gastroenterology|January 25, 2019
Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal AdenocarcinomaRaghuwansh P Sah, Ayush Sharma, Sajan Nagpal, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Cancer Biology|February 8, 2018
Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-β) signaling: An insight into Neuropilin-1 (NRP1) mediated tumorigenesisSneha Vivekanandhan, Debabrata Mukhopadhyay
Cancers|October 27, 2022
Resistance to TrastuzumabSneha Vivekanandhan, Keith L Knutson
Molecular Cancer|February 2, 2023
Immunotherapies in rare cancersSneha Vivekanandhan, Deborah Bahr, Ashish Kothari, et al.
Scientific Reports|October 19, 2024
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanomaEmmanuel M Gabriel, Brian Necela, Deborah Bahr, et al.
Scientific Reports|October 12, 2017
Genetic status of KRAS modulates the role of Neuropilin-1 in tumorigenesisSneha Vivekanandhan, Lijuan Yang, Ying Cao, et al.
Research Square|April 22, 2024
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanomaEmmanuel M Gabriel, Brian Necela, Deborah Bahr, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 13, 2022
Fluconazole Is Neuroprotective via Interactions with the IGF-1 ReceptorValerie Toodle, Myoung-Hwa Lee, Muzna Bachani, et al.
Cancers|August 27, 2021
Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Status of <i>KRAS</i>Sneha Vivekanandhan, Vijay S Madamsetty, Ramcharan Singh Angom, et al.
Gastroenterology|January 25, 2019
Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal AdenocarcinomaRaghuwansh P Sah, Ayush Sharma, Sajan Nagpal, et al.
Pageof 1